Baupost Group Discloses 35 Percent Stake In Idenix Pharmaceuticals

Baupost Group, the hedge fund founded and managed by Seth Klarman, disclosed ownership of 53,331,109 shares (a 35.38% stake) in Idenix Pharmaceuticals Inc (NASDAQ:IDIX) based on its 13D filing with the Securities and Exchange Commission (SEC), and as first reported by ValueWalk.

Baupost 35% $IDIX http://t.co/ezUXizp5iZ

— ValueWalk.com (@valuewalk) February 4, 2014

The hedge fund increased its stock holdings in Idenix Pharmaceuticals Inc (NASDAQ:IDIX) by 44.49% from its previous position of 36,910,869 shares at the end of December 2013.

Baupost Group receives observer rights

Based...